Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance

Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance

Item
http://www.wikidata.org/entity/Q26799848
An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo.Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-ASUrsolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer.EphA2 affects the sensitivity of oxaliplatin by inducing EMT in oxaliplatin-resistant gastric cancer cells.Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.Platinum-based drugs: past, present and future.Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.Reactive oxygen species mediate oxaliplatin-induced epithelial-mesenchymal transition and invasive potential in colon cancer.Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer.Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance.A fluorescent oxaliplatin derivative for investigation of oxaliplatin resistance using imaging techniques.Polymeric micelles for targeted tumor therapy of platinum anticancer drugs.Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells.HCN2 contributes to oxaliplatin-induced neuropathic pain through activation of the CaMKII/CREB cascade in spinal neurons.Huaier Augmented the Chemotherapeutic Sensitivity of Oxaliplatin via Downregulation of YAP in Hepatocellular Carcinoma
P2860

Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance

Item
http://www.wikidata.org/entity/Q26799848
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
@ast
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
@en
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
@nl
type
label
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
@ast
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
@en
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
@nl
prefLabel
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
@ast
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
@en
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P3181
P356
P1433
P1476
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
@en
P2093
P304
P31
P3181
P356
10.1158/1535-7163.MCT-14-0636
P407
P433
P478
P50
P577
P5875
P698